Inhaled iloprost for the control of pulmonary hypertension

References

• OlschewskiHDana Point: what is new in the diagnosis of pulmonary hypertension?Dtsch Med Wochenschr2008133S618018218213549
   PubMedGoogle Scholar
• OlschewskiHRoseFGruenigECellular pathophysiology and therapy of pulmonary hypertensionJ Lab Clin Med2001138636737711753283
   PubMedGoogle Scholar
• RubinLJDiagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelinesChest20041267S10S15249491
   PubMed Web of Science ®Google Scholar
• D′AlonzoGEBarstRJAyresSMSurvival in patients with primary pulmonary hypertension. Results from a national prospective registryAnn Int Med199111553433491863023
   PubMed Web of Science ®Google Scholar
• Gomberg-MaitlandMPrestonIRProstacyclin therapy for pulmonary arterial hypertension: new directionsSemin Respir Crit Care Med200526439440116121316
   PubMed Web of Science ®Google Scholar
• WelshCHassellKBadeschDCoagulation and fibrinolytic profiles in patients with severe pulmonary hypertensionChest19961107107178797416
   PubMed Web of Science ®Google Scholar
• ChristmanBWMcPhersonCDNewmanJHAn imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertensionN Engl J Med1992327270751603138
   PubMed Web of Science ®Google Scholar
• GeraciMWGaoBShepherdDCPulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertensionJ Clin Invest1999103111509151510359560
   PubMed Web of Science ®Google Scholar
• NagayaNYokoyamaCKyotaniSGene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in ratsCirculation2000102162005201011034952
   PubMed Web of Science ®Google Scholar
• TuderRMCoolCDGeraciMWProstacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertensionAm J Resp Crit Care Med199915961925193210351941
   PubMed Web of Science ®Google Scholar
• HervéPLaunayJMScrobohaciMLIncreased plasma serotonin in primary pulmonary hypertensionAm J Med1995992492547653484
   PubMed Web of Science ®Google Scholar
• ChengYAustinSCRoccaBRole of prostacyclin in the cardiovascular response to thromboxane A2Science200229653911964481
   PubMed Web of Science ®Google Scholar
• BlumbergFCRieggerGAPfeiferMHemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exerciseChest200212151566157112006445
   PubMed Web of Science ®Google Scholar
• McLaughlinVVGenthnerDEPanellaMMReduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertensionN Engl J Med199833852732779445406
   PubMed Web of Science ®Google Scholar
• SitbonOHumbertMNunesHLong-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survivalJ Am Coll Cardiol200240478078812204511
   PubMed Web of Science ®Google Scholar
• BadeschDBTapsonVFMcGoonMDContinuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trialAnn Intern Med2000132642543410733441
   PubMed Web of Science ®Google Scholar
• HigenbottamTWButtAYDinh-XaunATTreatment of pulmonary hypertension with the continous infusion of a prostacyclin analogue, iloprostHeart1998791751799538312
   PubMed Web of Science ®Google Scholar
• SimmoneauGBarstRJGalièNContinuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trialAm J Resp Crit Care Med2002165680080411897647
   PubMed Web of Science ®Google Scholar
• GalièNHumbertMVachiéryJLEffects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trialJ Am Coll Cardiol20023991496150211985913
   PubMed Web of Science ®Google Scholar
• BarstRJMcGoonMMcLaughlinVVBeraprost therapy for pulmonary arterial hypertensionJ Am Coll Cardiol200341122119212512821234
   PubMed Web of Science ®Google Scholar
• NagayaNUematsuMOkanoYEffect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertensionJ Am Coll Cardiol19993441188119210520811
   PubMed Web of Science ®Google Scholar
• OlschewskiHWalmrathDSchermulyRAerosolized Prostacyclin and Iloprost in Severe Pulmonary HypertensionAnn Intern Med199612498208248610951
   PubMed Web of Science ®Google Scholar
• KrauseWKraisTPharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in manEur J Clin Pharmacol198630161682423342
   PubMed Web of Science ®Google Scholar
• GesslerTSchmehlTHoeperMMUltrasonic versus jet nebulization of iloprost in severe pulmonary hypertensionEur Resp J20011711419
   PubMed Web of Science ®Google Scholar
• HoeperMMSchwarzeMEhlerdingSLong-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogueN Engl J Med2000343191866187010861321
   PubMedGoogle Scholar
• Ventavis (iloprost) [package insert]South San Francisco, CalifActelion Pharmaceuticals US, Inc2006
   Google Scholar
• SchermulyRTSchulzAGhofraniAPharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungsJ Pharmacol Exp Ther2002303274174512388660
   PubMed Web of Science ®Google Scholar
• OlschewskiHSimonneauGGalièNInhaled iloprost for severe pulmonary hypertensionN Engl J Med2002347532232912151469
   PubMed Web of Science ®Google Scholar
• EwertROpitzCWenselRIloprost as inhalational and intravenous long-term treatment of patients with primary pulmonary hypertension. Register of the Berlin Study Group for Pulmonary HypertensionZ Kardiol2000891198799911149275
   PubMedGoogle Scholar
• WalmrathDSchneiderTPilchJAerosolised prostacyclin in adult respiratory distress syndromeLancet19933429619628105216
   PubMed Web of Science ®Google Scholar
• WelteMZwisslerBHabazettlHPG12 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstrictionEur Surg Res1993253293408404993
   PubMed Web of Science ®Google Scholar
• OlschewskiHGhofraniAWalmrathDInhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosisAm J Resp Crit Care Med1999160260060710430735
   PubMed Web of Science ®Google Scholar
• WenselROpitzCFEwertREffects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertensionCirculation20001012388239210821815
   PubMed Web of Science ®Google Scholar
• HoeperMMOlschewskiHGhofraniAA comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study groupJ Am Coll Cardiol200035117618210636277
   PubMedGoogle Scholar
• OlschewskiHGhofraniHASchmehlTInhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study GroupAnn Intern Med2000132650050210733452
   PubMed Web of Science ®Google Scholar
• HoeperMMSchwarzeMEhlerdingSLong-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogueN Engl J Med2000342251866187010861321
   PubMed Web of Science ®Google Scholar
• OlschewskiHSimonneauGGalièNInhaled iloprost for severe pulmonary hypertensionN Engl J Med2002347532232912151469
   PubMed Web of Science ®Google Scholar
• OpitzCFWenselRWinklerJClinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertensionEur Heart J200526181895190215888496
   PubMed Web of Science ®Google Scholar
• FruhwaldFMKjellströmBPertholdWContinous hemodynamic monitoring in pulmonary hypertensive patients treated with inhaled iloprostChest200312435135912853544
   PubMed Web of Science ®Google Scholar
• MerelesDEwertRLodziewskiSEffect of inhaled iloprost during off-medication time in patients with pulmonary arterial hypertensionRespiration20077449850217449958
   PubMed Web of Science ®Google Scholar
• DomenighettiGMIdiopathic pulmonary arterial hypertension and inhaled iloprost: Good night rebound effects?Respiration200774549649717671405
   PubMed Web of Science ®Google Scholar
• OpitzCFWenselRBettmannMAssessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalationEur Heart J20032435636512581683
   PubMed Web of Science ®Google Scholar
• SchenkPPetkovVMadlCAerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertensionChest200111929630011157622
   PubMed Web of Science ®Google Scholar
• HoeperMMSpiekerkoetterEWesterkampVIntravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertensionEur Respir J200220233934312212965
   PubMed Web of Science ®Google Scholar
• LaunayDHachullaEHatronPYAerosolized iloprost in CREST syndrome related pulmonary hypertensionJ Rheumatol200128102252225611669165
   PubMed Web of Science ®Google Scholar
• HalliogluODilberECelikerAComparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart diseaseAm J Cardiol20039281007100914556887
   PubMed Web of Science ®Google Scholar
• PengoVLensingAWPrinsMHIncidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismN Engl J Med20043502257226415163775
   PubMed Web of Science ®Google Scholar
• LangIMChronic thromboembolic pulmonary hypertension – not so rare after allN Engl J Med20043502236223815163772
   PubMed Web of Science ®Google Scholar
• KrammTEberleBGuthSInhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomyEur J Cardiothorac Surg200528688288816242948
   PubMed Web of Science ®Google Scholar
• WebbSAStottSvan HeerdenPVThe use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolismIntensive Care Med19962243533558708174
   PubMed Web of Science ®Google Scholar
• Roig FigueroaVHerrero PérezAde la Torre FerreraNIloprost for Chronic thromboembolic pulmonary hypertensionArch Bronconeumol200440732632815225519
   PubMed Web of Science ®Google Scholar
• UlrichSFischlerMSpeichRChronic Thromboembolic and Pulmonary Arterial Hypertension share acute vasoreactivity propertiesChest200613084184616963684
   PubMed Web of Science ®Google Scholar
• KrugSHammerschmidtSPankauHAcute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertensionRespiration200876215415917804899
   PubMed Web of Science ®Google Scholar
• Ahmadi-SimabKKoehlerAGrossWLSustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosisClin Exp Rheumatol200725576076218078629
   PubMed Web of Science ®Google Scholar
• HoeperMMSeyfarthHJHoeffkenGExperience with inhaled iloprost and bosentan in portopulmonary hypertensionEur Respir J20073061038104018055701
   PubMed Web of Science ®Google Scholar
• SchermulyRTKrupnikETenorHCoaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivityAm J Respir Crit Care2001164916941700
   PubMed Web of Science ®Google Scholar
• WilkensHGuthAKoenigJEffect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertensionCirculation2001104111218122211551870
   PubMed Web of Science ®Google Scholar
• GhofraniHARoseFSchermulyRTOral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertensionJ Am Coll Cardiol200342115816412849677
   PubMed Web of Science ®Google Scholar
• HoeperMMTahaNBekjarovaABosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoidsEur Respir J200322233033412952269
   PubMed Web of Science ®Google Scholar
• SeyfarthHJPankauHHammerschmidtSBosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapyChest2005128270971316100158
   PubMed Web of Science ®Google Scholar
• McLaughlinVVOudizRJFrostARandomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertensionAm J Respir Crit Care Med20061741257126316946127
   PubMed Web of Science ®Google Scholar
• HoeperMMLeuchteHHalankMCombining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertensionEur Respir J20062869169417012628
   PubMed Web of Science ®Google Scholar
• RamakrishnaGSprungJRaviBSImpact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortalityJ Am Coll Cardiol2005451691169915893189
   PubMed Web of Science ®Google Scholar
• RinneTZwisslerBIntraoperative anaesthesiologic management of patients with pulmonary hypertensionIntensiv Notfallbeh2004291413
   Google Scholar
• RobertsNVKeastPJPulmonary hypertension and pregnancy: a lethal combinationAnesth Intensive Care199018366374
   PubMed Web of Science ®Google Scholar
• FischerLGVan AkenHBurkleHManagement of pulmonary hypertension: physiological and pharmacological considerations for anaesthesiologistsAnesth Analg2003961603161612760982
   PubMed Web of Science ®Google Scholar
• FoxCKalarickalPLYarboroughMJPerioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgeryCurr Opin Anaesthesiol20082146747218660654
   PubMed Web of Science ®Google Scholar
• KhanMJBhattSBKryeJJAnesthetic considerations for parturients with primary pulmonary hypertension: review of the literature and clinical presentationInt J Obstet Anesth19965364215321380
   PubMedGoogle Scholar
• BlaiseGLanglebenDHubertBPulmonary arterial hypertension. Pathophysiology and anesthetic approachAnesthesiology20039961415143214639158
   PubMed Web of Science ®Google Scholar
• SubramaniamKYaredJPManagement of pulmonary hypertension in the operating roomSem Cardiothoracic Vasc Anesth2007114119136
   PubMedGoogle Scholar
• SablotzkiAStarzmannWScheubelRSelective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidatesCan J Anaesth200552101076108216326679
   PubMed Web of Science ®Google Scholar
• HaraldssonAKieler-JensenNRickstenSEThe additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertensionAnesth Analg20019361439144511726420
   PubMed Web of Science ®Google Scholar
• WinterhalterMSimonAFischerSComparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass ion cardiac surgery: a prospective randomized trialJ Cardiothorac Vasc Anesth200822340641318503929
   PubMed Web of Science ®Google Scholar
• KurzynaMDabrowskiMBieleckiDAtrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertensionChest2007131497798317426198
   PubMed Web of Science ®Google Scholar
• AtzAMLeflerAKFairbrotherDLSildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertension crisesJ Thorac Cardiovasc Surg200212462862912202882
   PubMed Web of Science ®Google Scholar
• HoeperMMOlschewskiHHosseinAA comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertensionJ Am Coll Cardiol20003517618210636277
   PubMed Web of Science ®Google Scholar